ÜbersichtsarbeitOpen Access
Follicular Lymphoma: a Focus on Current and Emerging Therapies
ONCOLOGY · 2022
DOI: 10.46883/2022.25920946 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ONCOLOGY, 2022. Verfasst von Kirk E Cahill und 1 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Antibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsBendamustine HydrochlorideBenzamidesBiphenyl CompoundsBridged Bicyclo Compounds, HeterocyclicCyclophosphamideDoxorubicinGenetic TestingHumansImmune Checkpoint InhibitorsImmunoconjugatesImmunotherapy, AdoptiveLenalidomideLymphoma, FollicularMaintenance ChemotherapyMorpholinesNeoplasm Recurrence, LocalPhosphoinositide-3 Kinase InhibitorsPrednisone
Substanzen
Antibodies, Monoclonal, HumanizedBenzamidesBiphenyl CompoundsBridged Bicyclo Compounds, HeterocyclicImmune Checkpoint InhibitorsImmunoconjugatesMorpholinesPhosphoinositide-3 Kinase InhibitorsPyridonesR-CHOP protocol
Förderung
- NCI NIH HHS
Zitieren
APA
Cahill, K. E., & Smith, S. M. (2022). Follicular Lymphoma: a Focus on Current and Emerging Therapies. ONCOLOGY. https://doi.org/10.46883/2022.25920946
Vancouver
Cahill KE, Smith SM. Follicular Lymphoma: a Focus on Current and Emerging Therapies. ONCOLOGY. 2022. doi:10.46883/2022.25920946
BibTeX
@article{Cahill2022,
author = {Cahill, Kirk E and Smith, Sonali M},
title = {Follicular Lymphoma: a Focus on Current and Emerging Therapies},
journal = {ONCOLOGY},
year = {2022},
doi = {10.46883/2022.25920946}
}
EUVIMED